imec
VC Fund
Leuven, Belgium
imec is a VC fund in Leuven focused on Artificial Intelligence and Health Care. Imec* is a world-leading independent research center in nanoelectronics and nanotechnology. Imec is headquartered in Leuven, Belgium, and has offices in Belgium, the Netherlands, Taiwan, US, China and Japan.Its staff of more than 1,650 people include over 550 industrial residents and guest researchers. In 2008, imec's revenue (P&L) was270 million euro.Imec's More Moore research targets semiconductor scaling for the 22nm technology node and beyond. With its More than Moore research, imec invents technology for nomadic embedded systems, wireless autonomous transducer solutions, biomedical electronics, photovoltaics, organic electronics and GaN power electronics. Imec's research bridges the gap between the fundamental research at universities and R&D in the industry. It has unique processing and system know-how, intellectual property portfolio, state-of-the-art infrastructure, and a strong and worldwide network position. This makes imec a key partner for shaping the technology of the future.*imec is a registered trademark for the activities of imec International (a legal entity set up under Belgian law as a "stichting van openbaar nut“), imec Belgium (imec vzw supported by the Flemish Government), imec the Netherlands (Stichting imec Nederland, part of Holst Centre which is supported by the Dutch Government) and imec Taiwan (imec Taiwan Co.).
- Total investments:
- 16
- Last investment:
- Lead investor:
- 19%
- Fund size:
- $13M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries imec invests in
Stages imec invests in
Countries imec invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Arnaud Furnemont
|
|||
Arye Lipman
|
|||
Filip Gossele
|
|||
Kris Myny
|
|||
Liesbet Lagae
|
|||
| See all 21 contacts → | |||
Investment Focus
Industry
- Artificial Intelligence 5 (31%)
- Health Care 3 (19%)
- Semiconductor 3 (19%)
- Machine Learning 3 (19%)
- Medical 2 (13%)
Stage
- Seed 6 (38%)
- Series A 5 (31%)
- Pre-Seed 4 (25%)
Country
- Belgium 8 (50%)
- United States 3 (19%)
- Germany 1 (6%)
- The Netherlands 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Arnaud Furnemont
Memory Department Director
|
Memory Department Director | Total investments: 0 | Find email | |
|
Arye Lipman
Strategic Partnerships - Americas
|
Strategic Partnerships - Americas | Total investments: 0 | Find email | |
|
Filip Gossele
Agile Project Lead in the Cities Team
|
Agile Project Lead in the Cities Team | Total investments: 0 | Find email | |
|
Kris Myny
Principal Member Of Technical Staff
|
Principal Member Of Technical Staff | Total investments: 0 | Find email | |
|
Liesbet Lagae
Program Director Life Science Technologies
|
Program Director Life Science Technologies | Total investments: 0 | Find email | |
| See all 21 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Atlas Data Storage
|
Atlas Data Storage develops data storage systems utilizing synthetic DNA to encode digital information. The company offers end-to-end solutions that integrate semiconductor-based synthesis and enzyme engineering to store data in DNA strands. This approach aims to provide long-term, high-density storage options for various sectors. Atlas DataStorage's technology is designed to address the growing demand for scalable and energy-efficient data storage solutions. | Seed / Mar 05, 2026 | |
Vertical Compute
|
Vertical Compute offers chiplet-based technology that cuts data movement to achieve up to 80% energy savings. | $42.9M / Seed / Mar 04, 2026 | |
|
Vertical Compute
|
Vertical Compute offers chiplet-based technology that cuts data movement to achieve up to 80% energy savings. | $20.6M / Seed / Jan 14, 2025 | |
MICLEDI Microdisplays
|
MICLEDI Microdisplays is an experienced executive in the semiconductor industry, | $25M / Series A / Mar 12, 2024 | |
OTIV
|
Teaching vehicles on rails to drive autonomously. | Series A / Jan 12, 2023 | |
Axelera AI
|
Axelera AI is a company that delivers purpose-built hardware and software platforms designed to accelerate artificial intelligence tasks, particularly in edge computing. The company's flagship product, the Metis™ AI Platform, integrates both hardware and software components to deliver high-performance, energy-efficient AI inference solutions.This platform has been recognized for its innovation, notably being named a CES® 2024 Innovation Awards Honoree.Incubated in 2019 by the emerging technologies leader Bitfury and joined by the leading nano-technology group imec in early 2020, Axelera AI launched as a new company in 2021. Headquartered in the AI Innovation Center of the High Tech Campus in Eindhoven, Axelera AI has R&D offices in Belgium, Switzerland, and Italy. Its team of experts in AI software and hardware hail from top AI firms and Fortune 500 companies. | $12M / Seed / Sep 15, 2021 | |
Asylia Diagnostics
|
Asylia Diagnostics is a diagnostics technology platform intended to provide safer immunotherapy for cancer patients. We collect molecular and real-world evidence data from patients treated with investigational drugs in clinical trials and patients treated by the standard of care. We then use our data platform and AI-powered technology to transformthese highly heterogeneous patient populations into well-defined subgroups that share common molecular and immuno-pathophysiology profiles. By doing this, we are able to identify highly specific biomarkers and novel drug targets. We then use discovered endotypes, biomarkers, and drug targets to develop patient stratification, enrichment, and indication expansion strategies, early hits/leads for the therapeutic pipeline, and eventually complex theranostic products together with our biopharma and IVD partners. | $1.1M / Seed / Jul 12, 2021 | |
|
Asylia Diagnostics
|
Asylia Diagnostics is a diagnostics technology platform intended to provide safer immunotherapy for cancer patients. We collect molecular and real-world evidence data from patients treated with investigational drugs in clinical trials and patients treated by the standard of care. We then use our data platform and AI-powered technology to transformthese highly heterogeneous patient populations into well-defined subgroups that share common molecular and immuno-pathophysiology profiles. By doing this, we are able to identify highly specific biomarkers and novel drug targets. We then use discovered endotypes, biomarkers, and drug targets to develop patient stratification, enrichment, and indication expansion strategies, early hits/leads for the therapeutic pipeline, and eventually complex theranostic products together with our biopharma and IVD partners. | $1.1M / Pre-Seed / Mar 02, 2020 | |
conductiv.ai
|
conductiv.ai combines machine learning with physics-based simulation to maximize production yield for precision manufacturing. | Pre-Seed / Oct 29, 2019 | |
Onera Health
|
Onera Health is a leader in transforming sleep medicine and remote monitoring. Their breakthrough diagnostic solutions and services are poised to help millions of people struggling with sleep-related ailments while also impacting other medical fields by monitoring various chronic conditions, ultimately improving the health and quality of life ofpatients worldwide. The company’s innovative solutions provide comprehensive sleep test data to physicians in a variety of clinical and non-clinical environments to optimize patient care and reduce healthcare costs. Onera has offices in the Netherlands and the US. | $8.7M / Series A / Apr 24, 2019 | |
| See all 16 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does imec invest in?
imec invests primarily in Artificial Intelligence, Health Care and Semiconductor startups, most often at Seed and Series A stage. Most of the 16 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact imec?
Public channels for imec include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at imec?
The team at imec includes Arnaud Furnemont (Memory Department Director), Arye Lipman (Strategic Partnerships - Americas) and Filip Gossele (Agile Project Lead in the Cities Team), among 21 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
